I. Bliziotis

发表

Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?

M. Falagas, I. Bliziotis, 2007, International journal of antimicrobial agents.

Eighteen years of research on AIDS: contribution of and collaborations between different world regions.

M. Falagas, E. Soteriades, I. Bliziotis, 2006, AIDS research and human retroviruses.

Worldwide research productivity in critical care medicine

M. Falagas, A. Michalopoulos, I. Bliziotis, 2005, Critical care.

Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence.

M. Falagas, V. Tam, I. Bliziotis, 2007, International journal of antimicrobial agents.

Science in Greece: from the age of Hippocrates to the age of the genome

M. Falagas, G. Samonis, I. Bliziotis, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Failure to control risk factors among patients with type 2 diabetes; experience from a Greek cohort.

A. Kollias, I. Bliziotis, A. Xilomenos, 2009, Primary care diabetes.

Impact of initial discordant treatment with beta-lactam antibiotics on clinical outcomes in adults with pneumococcal pneumonia: a systematic review.

M. Falagas, I. Siempos, G. Panos, 2006, Mayo Clinic proceedings.

β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis.

M. Falagas, I. Bliziotis, K. Vardakas, 2013, International journal of antimicrobial agents.

Role of glycopeptides as part of initial empirical treatment of febrile neutropenic patients: a meta-analysis of randomised controlled trials.

M. Falagas, G. Samonis, I. Bliziotis, 2005, The Lancet. Infectious diseases.

Impact of Definitive Therapy with Beta-Lactam Monotherapy or Combination with an Aminoglycoside or a Quinolone for Pseudomonas aeruginosa Bacteremia

M. Falagas, A. Michalopoulos, G. Samonis, 2011, PloS one.

Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: a systematic review of the evidence from comparative trials.

M. Falagas, I. Bliziotis, K. Fragoulis, 2007, American journal of infection control.

Oral rifampin for prevention of S. aureus carriage-related infections in patients with renal failure--a meta-analysis of randomized controlled trials.

M. Falagas, I. Bliziotis, K. Fragoulis, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Ovarian cancer and oral contraceptives

I. Bliziotis, 2008, The Lancet.

The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa.

M. Falagas, I. Bliziotis, P. Koletsi, 2006, Journal of medical microbiology.

Limitations in the Management of Aortic Graft Infections

M. Falagas, S. Kasiakou, I. Bliziotis, 2006, Annals of vascular surgery.

Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis

M. Netea, G. Chatellier, M. Sormani, 2021, The Lancet Rheumatology.

Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria

M. Falagas, A. Michalopoulos, G. Samonis, 2005, BMC infectious diseases.

A bibliometric analysis of global trends of research productivity in tropical medicine.

Matthew E Falagas, M. Falagas, I. Bliziotis, 2006, Acta tropica.

Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies

Matthew E Falagas, M. Falagas, I. Siempos, 2006, Critical care.

Early Anakinra Treatment for COVID-19 Guided by Urokinase Plasminogen Receptor

S. Ktena, E. Nicastri, L. Dagna, 2021, medRxiv.

Early Treatment of COVID-19 Pneumonia with Anakinra Guided by Urokinase Plasminogen Receptor

M. Netea, S. Ktena, G. Ippolito, 2021 .

Thrombotic microangiopathy associated with gemcitabine: rare but real

M. Saif, K. Syrigos, I. Bliziotis, 2009, Expert opinion on drug safety.

Outcomes after medical and surgical treatment of diverticulitis: A systematic review of the available evidence

M. Falagas, I. Bliziotis, G. Peppas, 2007, Journal of gastroenterology and hepatology.

Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis

G. Stergiou, George S Stergiou, I. Bliziotis, 2012, Journal of hypertension.

Home blood pressure monitoring in the diagnosis and treatment of hypertension: a systematic review.

G. Stergiou, I. Bliziotis, 2011, American journal of hypertension.

Unusual climatic conditions and infectious diseases: observations made by Hippocrates.

M. Falagas, I. Bliziotis, J. Kosmidis, 2010, Enfermedades infecciosas y microbiologia clinica.

Case-control studies reporting on risk factors for emergence of antimicrobial resistance: bias associated with the selection of the control group.

M. Falagas, P. Rafailidis, I. Bliziotis, 2010, Microbial drug resistance.

Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

M. Netea, S. Ktena, E. Nicastri, 2021, Nature medicine.

Do high doses of quinolones decrease the emergence of antibacterial resistance? A systematic review of data from comparative clinical trials.

M. Falagas, P. Rafailidis, I. Bliziotis, 2007, The Journal of infection.

Vaccination against typhoid fever in travellers: a cost-effectiveness approach.

M. Falagas, I. Bliziotis, M. Falagas, 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Regression of subcorneal pustular dermatosis type of IgA pemphigus lesions with azithromycin.

M. Falagas, P. Rafailidis, I. Bliziotis, 2005, The Journal of infection.

Albendazole for the Treatment of Human Echinococcosis: A Review of Comparative Clinical Trials

M. Falagas, I. Bliziotis, 2007, The American journal of the medical sciences.

Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials.

M. Falagas, G. Samonis, I. Bliziotis, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Helicobacter pylori infection in symptomatic HIV-seropositive and -seronegative patients: a case-control study.

M. Falagas, G. Panos, I. Bliziotis, 2007, AIDS research and human retroviruses.

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

M. Netea, S. Ktena, G. Ippolito, 2021, Nature Medicine.

Rifampin as adjuvant treatment of Gram-positive bacterial infections: a systematic review of comparative clinical trials

M. Falagas, I. Bliziotis, M. Falagas, 2007, European Journal of Clinical Microbiology & Infectious Diseases.

The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials.

M. Falagas, D. Matthaiou, I. Bliziotis, 2006, The Journal of antimicrobial chemotherapy.

Toxicity after prolonged (more than four weeks) administration of intravenous colistin

M. Falagas, A. Michalopoulos, S. Kasiakou, 2005, BMC infectious diseases.

Quinolones for Treatment of Human Brucellosis: Critical Review of the Evidence from Microbiological and Clinical Studies

M. Falagas, I. Bliziotis, 2006, Antimicrobial Agents and Chemotherapy.

Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials.

M. Falagas, A. Michalopoulos, G. Samonis, 2005, Mayo Clinic proceedings.

Spondylodiscitis after facet joint steroid injection: A case report and review of the literature

M. Falagas, P. Papagelopoulos, A. Mavrogenis, 2006, Scandinavian journal of infectious diseases.

Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials.

M. Falagas, I. Bliziotis, K. Fragoulis, 2007, The Journal of antimicrobial chemotherapy.

Worldwide trends in quantity and quality of published articles in the field of infectious diseases

M. Falagas, I. Bliziotis, P. Vergidis, 2005, BMC infectious diseases.

A prospective study of services utilization of a hospital-based employee health clinic.

M. Falagas, E. Soteriades, I. Bliziotis, 2006, Medical science monitor : international medical journal of experimental and clinical research.

Antibiotic-lock therapy for long-term catheter-related bacteremia: a review of the current evidence

M. Falagas, I. Bliziotis, I. Korbila, 2007, Expert review of anti-infective therapy.

Red streaks on the leg. Lymphangitis.

M. Falagas, I. Bliziotis, A. Kapaskelis, 2006, American family physician.

A bibliometric analysis of research productivity in Parasitology by different world regions during a 9-year period (1995–2003)

M. Falagas, I. Bliziotis, Paraskevi A Papastamataki, 2006, BMC infectious diseases.

Comparison of utility of blood cultures from intravascular catheters and peripheral veins: a systematic review and decision analysis.

M. Falagas, M. Kazantzi, I. Bliziotis, 2008, Journal of medical microbiology.

Morganella morganii Infections in a General Tertiary Hospital

M. Falagas, G. Samonis, E. Saloustros, 2006, Infection.

Ciprofloxacin/metronidazole versus beta-lactam-based treatment of intra-abdominal infections: a meta-analysis of comparative trials.

M. Falagas, D. Matthaiou, I. Bliziotis, 2006, International journal of antimicrobial agents.

M. Falagas, S. Kasiakou, I. Bliziotis, 2006, Infection.

Bibliometric analysis of global trends for research productivity in microbiology

M. Falagas, I. Bliziotis, P. Vergidis, 2005, European Journal of Clinical Microbiology and Infectious Diseases.

Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials

M. Falagas, I. Siempos, A. Michalopoulos, 2006, Critical care.

Trends in the methodological quality of published randomized controlled trials on antibacterial agents.

M. Falagas, I. Bliziotis, E. Pitsouni, 2008, British journal of clinical pharmacology.

Reply to Alfandari and Boussekey

M. Falagas, I. Bliziotis, 2005 .

Peripheral T-cell lymphoma masquerading as infectious cellulitis.

M. Falagas, P. Rafailidis, I. Bliziotis, 2007, European journal of dermatology : EJD.

Systematic review: fluoroquinolones for the treatment of intra‐abdominal surgical infections

M. Falagas, D. Matthaiou, I. Bliziotis, 2007, Alimentary pharmacology & therapeutics.

A bibliometric analysis by geographic area of published research in several biomedical fields, 1995–2003

Matthew E Falagas, M. Falagas, E. Soteriades, 2006, Canadian Medical Association Journal.

Comparison of utility of blood cultures from intravascular catheters and peripheral veins: a systematic review and decision analysis.

M. Falagas, M. Kazantzi, I. Bliziotis, 2008, Journal of medical microbiology.

Aminoglycosides in combination with a β-lactam for the treatment of bacterial endocarditis: authors' response

M. Falagas, D. Matthaiou, I. Bliziotis, 2006 .

Effect of a Policy for Restriction of Selected Classes of Antibiotics on Antimicrobial Drug Cost and Resistance

D. Nikita, A. Michalopoulos, I. Bliziotis, 2007, Journal of chemotherapy.